CHARACTERIZATION OF PROCONVULSANT MECHANISMS ON GABAERGIC NEUROTRANSMISSION IN CAENORHABDITIS ELEGANS

Epilepsy is a prevalent brain disorder that affects more than 1 in 26 people in the United States. The recurring increased neuronal excitability during seizures results in sleep disturbances and muscle convulsions that reduce the quality of life and increase the healthcare costs for these patients. An epilepsy diagnosis is made when patients have had two or more seizures. There are many types of seizures and an individual can have more than one type. Seizures are classified into two groups, 1) generalized seizures that affect both sides of the brain and 2) focal seizures that are located in just one area of the brain. The causes of epilepsy vary by the age of the person, some with no clear cause may have a genetic form of epilepsy. Due to the various causes and types of seizures, many treatments including invasive surgeries and antiepileptic drugs (AEDs) do not work for all epileptic/seizure patients and are merely used to ease symptoms. The physiological complexity of the disorder and limited knowledge on its specific molecular mechanisms may contribute to the lack of effective treatment. In recent years, there has been an estimated average cost in billions of dollars to bring new medicine to the market; due to the lack of novel antiseizure targets and mechanism-based therapies on seizure phenotypes. In response to this, we utilized the electroconvulsive seizure behavioral assay to characterize one generalized seizure phenotype, tonic-clonic/grand mal seizures.